Skip to main content
Clinical Trials/NCT00116987
NCT00116987TerminatedNot Applicable

Pacing the Octogenarian Plus Population (POPP) A Comparison of Physiologic Versus Ventricular Pacing in Those Who Are 80 Years of Age and Older

University of Calgary1 site in 1 country800 target enrollmentStarted: August 1, 2003Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
800
Locations
1
Primary Endpoint
To determine which pacing mode, physiologic or ventricular, is associated with a reduction in emergency room visits or hospitalizations for cardiovascular/cerebrovascular causes

Study Overview

Brief Summary

Of the 19,000 pacemakers implanted across Canada in 2002, 1/3 of them were for patients 80 years and older. This is the fastest growing segment of our population, yet no study has specifically been done in this age group to determine the optimal pacing mode.

We wish to determine whether dual chamber or single chamber pacing is associated with a reduction in emergency room visits or hospitalizations for cardiovascular causes (e.g., congestive heart failure (CHF), atrial fibrillation (AF)) resulting in improved quality of life.

Detailed Description

Many patients who are 80 years of age and older, develop AF or CHF. Physiologic pacing has been shown to prevent AF compared to ventricular pacing. Whether prevention of AF and CHF by physiologic pacing reduces emergency room visits or hospitalizations for cardiovascular causes in this population in unknown.

The investigators wish to determine the optimal pacing mode for this patient population that would enable optimal management of cardiovascular problems, resulting in improved quality of life and minimizing use of health care facilities.

Patients recruited to the study will be randomized to either DDDR or VVIR pacing, and followed in the clinic every 6 months for the 3 years of the study.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
80 Years to — (Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •80 years of age and older
  • •Symptomatic bradycardia

Exclusion Criteria

  • •Permanent atrial fibrillation
  • •Previous pacemaker implant
  • •Life expectancy less than 1 year
  • •Geographic isolation
  • •Unable to give informed consent

Arms & Interventions

1

Other

Physiologic pacemakers usually have two leads - one positioned in the right atrium (upper heart chamber) and one positioned in the right ventricle.

Intervention: Dual chamber cardiac pacemaker (Device)

2

Other

Ventricular pacemakers have a single lead (wire) positioned in the right ventricle (lower pumping chamber) to sense and pace the ventricle.

Intervention: Single chamber cardiac pacemaker (Device)

Outcomes

Primary Outcomes

To determine which pacing mode, physiologic or ventricular, is associated with a reduction in emergency room visits or hospitalizations for cardiovascular/cerebrovascular causes

Time Frame: approximately 3 - 5 years

Secondary Outcomes

  • To determine which pacing mode, physiologic or ventricular, is associated with improved functional capacity and improved quality of life(approximately 3 - 5 years)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dr. Anne M. Gillis

Professor of Medicine, University of Calgary

University of Calgary

Study Sites (1)

Loading locations...

Similar Trials